In this visit, which was attended by Mr. Dr. Ansari, the honorable general manager of the Food and Drug Organization reference laboratory, and a group of managers and expert experts of Sobhan Oncology, first, Dr. Mohammad Hossein Bigtan, the manager of Sobhan Oncology factory, a report on the company’s performance, product license, product development path, products Strategically, he explained the increase in the market share of Hazar products, the expansion of the company’s strategic cooperation with the licensed pharmaceutical companies, the entry into the market of pharmaceutical products with high technologies, the increase in income and export markets. While referring to the strategic products market, he added that this company as a leader,

It has a wide range of hazard products in the country. In addition, Mr. Dr. Ansari, while thanking Sobhan Oncology for his efforts, listed this company as one of the most important suppliers in the pharmaceutical market and added that Subhan Oncology has a special position with high technology due to the production of hazardous pharmaceutical products. In this regard, it is expected to meet a high percentage of the region’s needs and to place more products to developed countries at the top of its goals and plans.

Visiting production lines, laboratories, warehouses and technical facilities of Sobhan Oncology were the most important topics of this program.